Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature
Abstract Background We report the development of asymptomatic progressive multifocal leukoencephalopathy in a patient with multiple sclerosis on natalizumab therapy. Progressive multifocal leukoencephalopathy often presents with debilitating neurologic symptoms. Very few cases have documented a comp...
Main Authors: | Yinan Zhang, Crystal Wright, Angela Flores |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-018-1727-7 |
Similar Items
-
Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis
by: Maria N. Zakharova, et al.
Published: (2018-12-01) -
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
by: Eli Hatchwell, et al.
Published: (2022-12-01) -
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
by: Peggy S. Eis, et al.
Published: (2020-03-01) -
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: risk reduction, management and possibilities for subsequent immunoregulation
by: Natalia V. Khachanova, et al.
Published: (2019-12-01) -
Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy
by: Viviana Lo Buono, et al.
Published: (2022-04-01)